Skip to main content

Table 1 Routine statistics of ledger books: average monthly number of patients positive by m RDT, and ALu blisters & quinine vials issued by the main store, before and after m RDT implementation, in intervention and control health facilities.

From: Reduction of anti-malarial consumption after rapid diagnostic tests implementation in Dar es Salaam: a before-after and cluster randomized controlled study

Health facility

Patients positive bymRDT

Number per

monthn

ALu blisters ÂŁ

Quinine vials &

  

Before m RDT initiation*

Blisters per

month

n

After m RDT initiation#

Blistersper

month

n

Post-intervention blisters

as a proportion of

pre-intervention

PP (95% CI)

Before m RDT initiation$

Vialsper

month

n

After m RDT initiation#

Vialsper

month

n

Post-intervention vials

as a proportion of

pre-intervention

PP (95% CI)

Intervention health facilities

      

Hospital 1

495

4560

1326

0.29

3205

1503

0.47

Hospital 2

323

1500

307

0.20

5049

549

0.11

Hospital 3

335

3100

1608

0.52

1747

1048

0.60

Health centre 1

329

3000

1890

0.63

830

272

0.33

Health centre 2

209

1430

268

0.19

553

86

0.16

Health centre 3

93

1540

360

0.23

177

92

0.52

Dispensary 1

43

650

25

0.04

59

26

0.44

Dispensary 2

101

770

202

0.26

245

85

0.35

Dispensary 3

210

4110

1947

0.47

303

111

0.37

Total of 9 HFŦ

   

0.32 (0.20 - 0.43)

  

0.37 (0.28 - 0.46)

Total of 6 matched intervention HFŦ

0.30 (0.15 - 0.46)

  

0.36 (0.24 - 0.48)

Control health facilities

      

Control 1

N.A

1900

1952

1.03

280

766

2.73

Control 2

N.A

3410

1353

0.40

209

151

0.72

Control 3

N.A

4180

2617

0.63

217

871

4.01

Total of 3 matched control HFŦ

 

0.68 (0.46 - 0.91)

  

2.49 (1.62 - 3.35)

  1. £ One blister of ALU is needed for one anti-malarial course, whatever the age or weight of the patient, &Between 2 and 6 vials are used per anti-malarial course, * observation period of only 3 months because ALu only introduced in Tanzania in January 2007, # observation period of 18 months, $ observation period of 15 months, Ŧ allowing for random-effect.